A Phase III Study of Yoga for Chemotherapy-Related Nerve Pain

Share

Full Title

A Randomized Phase III Clinical Trial of Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT)

Purpose

Some chemotherapy drugs can cause numbness and/or nerve pain in the arms and legs, a condition called peripheral neuropathy. The purpose of this study is to assess the value of yoga for treating peripheral neuropathy in people still living with this discomfort after completing chemotherapy. Patients will be randomly assigned to one of three groups:

  • 8 weeks of yoga, accessible in person and virtually
  • 8 weeks of educational sessions discussing peripheral neuropathy and yoga
  • 8 weeks of usual care, such as medications

Participants in the two non-yoga groups will receive vouchers for ten free yoga sessions after completing the study.

Eligibility

This study will include people age 18 and older who completed nerve-damaging chemotherapy three or more months before entering the study, are free of cancer, and are still experiencing moderate to severe nerve pain. Participants may not be receiving physical therapy or practicing yoga before entering the study.

For more information about this study, please contact the Clinical Research Coordinator at 646-449-1033.

 

Protocol

21-096

Phase

III

Investigator

Co-Investigators